Richard Carvajal, MD, Columbia University Medical Center, discusses the importance of a multidisciplinary approach when monitoring patients for immunotherapy toxicities.

Nursing staff are vital when it comes to follow-up with patients on immunotherapy treatments. Daily phone calls may even be necessary to ensure that patients are monitored as needed. For combination immunotherapy treatments, Carvajal suggests using the wisdom seen in the single agents. Staff must be hypervigilant and there must be standards developed for follow-up and management of these patients.

Videos

Richard Carvajal, MD, discusses the importance of a multidisciplinary approach when monitoring patients for immunotherapy toxicities.


Richard Carvajal on Multidisciplinary Approach to Managing Immunotherapy Toxicities

Richard Carvajal, MD, from Columbia University Medical Center discusses deciding on dosing limits for immunotherapy treatments.

The proper dosing for immunotherapy efficacy is unclear. For chemotherapy, the patients can often be pushed to toxicity. However, with immunotherapies and targeted therapies, there are responses seen after 1 or 2 doses. There are also durable responses in some patients if treatment is stopped.

Richard Carvajal, MD, discusses how to make decisions regarding the dosing limits of immunotherapy agents. 

Richard Carvajal, MD

Articles

Richard Carvajal on Multidisciplinary Approach to Managing Immunotherapy Toxicities

Richard Carvajal on Immunotherapy Dosing